Jonathan Burdon

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen et al. · The Lancet · 2015 · 494 citations

Lung Density, Pulmonary Pharmacology, Placebo-controlled Trial +4

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes et al. · The Lancet Respiratory Medicine · 2016 · 191 citations · Full text

Open-label Extension Trial, Long-term Efficacy, Immunology +2

Asthma, allergy and atopy in Asian immigrants in Melbourne

Roland Leung, Jonathan Burdon, John B. Carlin et al. · The Medical Journal of Australia · 1994 · 160 citations

Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor

Jan Stolk, Robert A. Stockley, Berend C. Stoel et al. · European Respiratory Journal · 2012 · 94 citations · Full text

Adriamycin-lnduced Recall Phenomenon 15 Years After Radiotherapy

Jonathan Burdon · JAMA · 1978 · 78 citations

Topical Amphotericin B, Prior Radiation, Radiation Medicine +14